State of Wisconsin Investment Board
SNNA

State of Wisconsin Investment Board’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

State of Wisconsin Investment Board’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,900
Closed -$48K – 1643
2019
Q1 		$48K Buy
20,900
+4,800
+30% +$13K ﹤0.01% 1533
2018
Q4 		$37K Hold
16,100
– – ﹤0.01% 1533
2018
Q3 		$239K Buy
+16,100
New +$256K ﹤0.01% 1489

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State of Wisconsin Investment Board's SNNA Position: Q2 2019 in Review

State of Wisconsin Investment Board sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2019, closing a stake of 20,900 shares — an estimated $48K sold.

State of Wisconsin Investment Board first reported a position in SNNA in Q3 2018 and held it in 3 quarters. The position peaked at $239K in Q3 2018. 48 funds tracked by Wall St. Rank hold SNNA as of Q2 2019.

  • State of Wisconsin Investment Board reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 20,900 Sienna Biopharmaceuticals, Inc. shares in Q2 2019, an estimated $48K.
  • State of Wisconsin Investment Board first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Sienna Biopharmaceuticals, Inc. position peaked at $239K in Q3 2018.
  • 48 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2019, filed 14 Aug 2019.